IP Library Granted Patent US 11,168,056
Granted Patent B2
US 11,168,056 · App. 16/876,966 · Granted Nov 9, 2021

Process for the manufacturing of (6aR,10aR)-7-propyl-6,6a,7,8,9,10,10a,11-octahydro-[1,3]dioxolo[4′,5′:5,6]benzo[1,2-G]quinoline and (4aR,10aR)-1-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[G]quinoline-6,7-diol

Inventors: Mikkel Fog Jacobsen (Valby, DK); Martin Juhl (Valby, DK); Frans Dennis Therkelsen (Valby, DK); Kåre Søndergaard (Valby, DK); Tobias Gylling Frihed (Valby, DK)
Assignee: H. Lundbeck A/S
C07D215/06C07D317/60
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,168,056
App. No.
16/876,966
Granted
Nov 9, 2021
Kind
B2
Abstract

The present invention relates to a new process for manufacturing (6aR,10aR)-7-propyl-6,6a,7,8,9,10,10a,11-octahydro-[1,3]dioxolo[4′,5′:5,6]benzo[1,2-g]quinoline with formula (Ib) below, (4aR,10aR)-1-Propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[g]quinoline-6,7-diol with formula (I) below and salts thereof. Both compounds are for use in the treatment of neurodegenerative diseases and disorders such as Parkinson's Disease. The invention also relates to new intermediate compounds of said process.

Claims (53)

1. A process for the manufacture of compound (I) with the formula below

from the compound (Ib) with the formula below

wherein compound (Ib) is prepared by a process comprising the steps of:

Step 0)

Substep (i) reacting compound (A1) with 3-chloropropan-1-amine to obtain compound (a2i); or

Substep (S1) reacting compound (a6i) with tert-butyl 2-bromoacetate and zinc to form a mixture, followed by

treating the mixture from substep (S1) with acetic acid, followed by

reacting said mixture with 3-chloropropan-1-amine hydrochloride to afford compound (a2i);

followed by

Step 1)

Substep (ii) reducing the compound (a2i) obtained in substep (i) or substep (S1) to obtain compound (a2ii), followed by

Substep (iii) resolving compound (a2ii) using L-tartaric acid to afford compound (A2-hemi-L-tartrate);

or

Substep (i) or substep (S1) is followed by substep (iv) comprising the step of subjecting compound (a2i) to a hydrogenation performed with a chiral catalyst in the presence of hydrogen and a solvent to afford compound (A2);

according to the reaction scheme below:

2. The process according to claim 1 , wherein compound (Ib) is prepared by a process comprising the steps of:

Step 0)

Substep (S1)

reacting compound (a6i) with tert-butyl 2-bromoacetate and zinc to form a mixture, followed by

treating the mixture from substep (S1) with acetic acid, followed by

reacting said mixture with 3-chloropropan-1-amine hydrochloride to afford compound (a2i);

followed by

Step 1)

Substep (ii) reducing the compound (a2i) obtained in substep (S1) to obtain compound (a2ii), followed by

Substep (iii) resolving compound (a2ii) using L-tartaric acid to afford compound (A2-hemi-L-tartrate).

3. The process according to claim 1 , wherein the chiral catalyst in Step 1 substep (iv) is selected from (2S)-1-[(1S)-1-[bis(1,1-dimethylethyl)phosphino]ethyl]-2-(diphenylphosphino)ferrocene and bis(2,5-norbornadiene)rhodium(I) tetrafluoroborate.

4. The process according to claim 1 , wherein the solvent in Step 1 substep (iv) is 2,2,2-trifluoroethanol.

5. The process according to claim 1 , wherein the reduction in Step 1 substep (ii) takes place in the presence of a reducing agent selected from the group consisting of NaBH 3 CN, sodium triacetoxyborohydride (STAB), a borane, 5-ethyl-2-methylpyridine borane (PEMB) and NaBH 4 .

6. The process according to claim 1 , wherein the reduction in Step 1 substep (ii) takes place by use of a platinum catalyst.

7. A process for the manufacture of compound (I):

from compound (Ib):

wherein compound (Ib) is prepared by a process comprising the following step

2) reacting compound (A2) or compound (A2-hemi-L-tartrate) with propanal in the presence of a reducing agent,

to afford compound (A3) according to reaction scheme a) or b) below

8. A process for the manufacture of compound (I):

from compound (Ib):

wherein compound (Ib) is prepared by a process comprising the following step

3) reacting compound (A3) with a strong base, to afford compound A4 according to the reaction scheme below

optionally followed by isolating compound (A4), or a salt thereof.

9. The process according to claim 8 , wherein A4 is isolated as a HCl salt as depicted below

10. A process for the manufacture of compound (I):

from compound (Ib):

wherein compound (Ib) is prepared by a process comprising the following step

4) performing an intramolecular Friedel-Craft acylation of compound (A4) to afford compound (A5) according to the reaction scheme below:

optionally followed by isolating compound (A5), or a salt thereof.

11. A process for the manufacture of compound (I):

from compound (Ib):

wherein compound (Ib) is prepared by a process comprising the following step

5) reducing compound (A5), or a salt thereof, to obtain compound (Ib), or a salt thereof according to the reaction scheme below

12. The process according to claim 11 , wherein compound (I) is prepared from compound (Ib) by the following step

6) reacting compound (Ib) with a Lewis acid or Brønsted acid selected from the group consisting of BCl 3 , BBr 3 and HBr,

to obtain compound (I) according to the reaction scheme below

13. The process according to claim 6 , wherein the platinum catalyst is platinum on carbon.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2020
From: JUHL, MARTIN; JACOBSEN, MIKKEL FOG; FRIHED, TOBIAS GYLLING; THERKELSEN, FRANS DENNIS; SØNDERGAARD, KÅRE
To: H. LUNDBECK A/S
Reel/Frame 052888/0151 →
Priority Claims (1)
DK PA201900600 · May 20, 2019 · national
Continuity (1)
Related Publication 20200369615A1 · Nov 26, 2020
Cited By (8)
US 12,226,428 US 12,319,710 US 12,384,765 US 12,391,650 US 12,398,106 US 12,398,169 US 12,421,271 US 12,479,801